Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6974269 | 0.74 | CNR1 (0.41) | CNR1 | |
| SCHEMBL6979377 | 0.74 | NOS3 (0.38) | NOS3NOS1NOS2 | |
| SCHEMBL6979530 | 0.73 | SLC6A3 (0.39) | BACE1 | |
| SCHEMBL6979522 | 0.71 | KMT2A (0.31) | CNR1 | |
| SCHEMBL8546566 | 0.68 | — | — | |
| SCHEMBL5197876 | 0.67 | ALDH1A1 (0.39) | BACE1 | |
| SCHEMBL6798960 | 0.66 | NOS3 (0.45) | NOS3NOS1NOS2 | |
| SCHEMBL7624743 | 0.65 | ALDH1A1 (0.40) | BACE1 | |
| SCHEMBL11437129 | 0.65 | BACE1 (0.44) | BACE1 | |
| SCHEMBL3071586 | 0.64 | CRBN (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0821674-B1 | CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | SEARLE & CO (US) | 2003-08-06 | — | — | EP | disclosed |
| US-6011028-A | Cyclic amidino agents useful as nitric oxide synthase inhibitors | G.D. SEARLE & CO. (US) | 2000-01-04 | — | — | US | disclosed |
| WO-1996033175-A1 | CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | G.D. SEARLE & CO. (US) | 1996-10-24 | — | — | WO | disclosed |